Company · CIK 0001512762 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq
Coherus Oncology, Inc. · CHRS
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 10, 2015 JForm 4 → | Apr 3, 4:21 pm EDT | James HealyDirector | 335,507 | — | — | 2,893,221 | — | plan? late amended |
| Mar 10, 2015 JForm 4 → | Mar 12, 4:18 pm EDT | Dennis M LanfearPresident & CEO, Director | 1,631 | — | — | 86,952 | — | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 1, 2015 AForm 4 → | Apr 3, 4:23 pm EDT | Alan C. HermanChief Scientific Officer | 50,000 | — | — | 50,000 | — | |
| Apr 1, 2015 AForm 4 → | Apr 3, 4:22 pm EDT | Mats WahlstromDirector | 95,000 | — | — | 75,000 | — | amended |
| Apr 1, 2015 AForm 4 → | Apr 3, 4:21 pm EDT | James HealyDirector | 45,000 | — | — | 25,000 | — | amended |
| Apr 1, 2015 AForm 4 → | Apr 3, 4:20 pm EDT | Barbara K FinckChief Medical Officer | 100,000 | — | — | 100,000 | — | |
| Apr 1, 2015 AForm 4 → | Apr 3, 4:17 pm EDT | Jean-Frederic ViretChief Financial Officer | 100,000 | — | — | 100,000 | — | |
| Apr 1, 2015 AForm 4 → | Apr 3, 4:16 pm EDT | August J. TroendleDirector | 20,000 | — | — | 20,000 | — | amended |
| Apr 1, 2015 AForm 4 → | Apr 3, 4:14 pm EDT | Peter K. WatlerChief Technical Officer | 100,000 | — | — | 100,000 | — | |
| Dec 31, 2014 AForm 4 → | Jan 2, 2015, 5:18 pm EST | Ali J. SatvatDirector | 15,000 | — | — | 15,000 | — | |
| Dec 31, 2014 AForm 4 → | Jan 2, 2015, 5:17 pm EST | V Bryan LawlisDirector | 15,000 | — | — | 15,000 | — |